Emma H Baker

Author PubWeight™ 21.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Making medicines evergreen. BMJ 2012 2.74
2 Factors determining the appearance of glucose in upper and lower respiratory tract secretions. Intensive Care Med 2003 1.71
3 Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J Cyst Fibros 2006 1.30
4 Clinical importance of cystic fibrosis-related diabetes. J Cyst Fibros 2004 1.18
5 Effect of hyperglycaemia on glucose concentration of human nasal secretions. Clin Sci (Lond) 2004 1.16
6 Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose. Thorax 2013 1.12
7 Glucose homeostasis across human airway epithelial cell monolayers: role of diffusion, transport and metabolism. Pflugers Arch 2008 1.12
8 Sweet talk: insights into the nature and importance of glucose transport in lung epithelium. Eur Respir J 2012 1.02
9 Apical and basolateral localisation of GLUT2 transporters in human lung epithelial cells. Pflugers Arch 2008 1.01
10 Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis. J Cyst Fibros 2005 0.96
11 Elevated paracellular glucose flux across cystic fibrosis airway epithelial monolayers is an important factor for Pseudomonas aeruginosa growth. PLoS One 2013 0.94
12 Proinflammatory mediators disrupt glucose homeostasis in airway surface liquid. J Immunol 2012 0.93
13 COPD-related bronchiectasis; independent impact on disease course and outcomes. COPD 2014 0.87
14 Functional MRI demonstrates pain perception in hand osteoarthritis has features of central pain processing. J Biomed Graph Comput 2013 0.83
15 Fructose transport-deficient Staphylococcus aureus reveals important role of epithelial glucose transporters in limiting sugar-driven bacterial growth in airway surface liquid. Cell Mol Life Sci 2014 0.82
16 Blood glucose: of emerging importance in COPD exacerbations. Thorax 2009 0.82
17 Safety of Metformin in Patients with Chronic Obstructive Pulmonary Disease and Type 2 Diabetes Mellitus. COPD 2014 0.80
18 Phase II study of tight glycaemic control in COPD patients with exacerbations admitted to the acute medical unit. BMJ Open 2011 0.79
19 Hyperglycaemia in the acute care setting. Clin Med 2012 0.78
20 Understanding and managing medication in elderly people. Best Pract Res Clin Obstet Gynaecol 2013 0.76
21 Safety of metformin in patients with chronic obstructive pulmonary disease and type 2 diabetes mellitus. COPD 2015 0.75